GOLDSMITH MARK A sold RVMD
August 21, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 229 shares of Revolution Medicines, Inc. at $211.46 per share, a transaction worth $48.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
229
Price
$211.46
Total value
$48.4K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 21, 2026
Filing dateAugust 25, 2026
Shares owned after61,550
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Held by Rebecca Goldsmith Revocable Trust.